Google AI策略解析 擴展GDevice及吸引第三方應用開發者為當務之急 AutoML為Google Cloud殺手鐧

2018-02-13 13:46:38 DIGITIMES

Google執行長(CEO) Sundar Pichai於2017年5月Google I/O大會提出Google將從Mobile First公司轉變為AI First公司,事實上,Google快速將AI服務滲透到其傳統GMS(Google Mobile Service)服務領域,Google用戶早已不知不覺在包括搜尋、Gmail、Maps及YouTube等服務中使用了Google的AI技術。然而,在Goog......

閱讀全文
  • 相關廠商

    建誼生技股份有限公司

    Founded and managed by a group of experienced scientists previously working at ScinoPharm Taiwan’s custom synthesis team, KriSan Biotech offers world class services of new drug process and analytical R&D for small molecules and peptides from Pre-clinical (IND) to Phase II. KriSan Biotech was formed to provide high quality chemistry process and analytical R&D services with Asian advantages and western know-how. The company occupies 2,700 m² of suites located in Southern Taiwan Science Park, we are proud to provide the following services: • Process and analytical R&D for small molecules and peptides from Pre-clinical to Phase II • CGMP manufacturing of API for clinical trials (few grams to kilograms scale) • Stability test in accordance to ICH guidelines • CMC Preparation for IND Filing


    建誼生技股份有限公司

    Founded and managed by a group of experienced scientists previously working at ScinoPharm Taiwan’s custom synthesis team, KriSan Biotech offers world class services of new drug process and analytical R&D for small molecules and peptides from Pre-clinical (IND) to Phase II. KriSan Biotech was formed to provide high quality chemistry process and analytical R&D services with Asian advantages and western know-how. The company occupies 2,700 m² of suites located in Southern Taiwan Science Park, we are proud to provide the following services: • Process and analytical R&D for small molecules and peptides from Pre-clinical to Phase II • CGMP manufacturing of API for clinical trials (few grams to kilograms scale) • Stability test in accordance to ICH guidelines • CMC Preparation for IND Filing